Showing results (31-40 of 118) with videos related to
Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrationsSilke Schuttrumpf, Lutz Binder, Thorsten Hagemann, et al.Nature Reviews. Immunology|October 3, 2002
Anti-inflammatory lipid mediators and insights into the resolution of inflammationToby Lawrence, Derek A Willoughby, Derek W GilroyThe EMBO Journal|April 17, 2014
Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programmingMarc Dalod, Rabie Chelbi, Bernard Malissen, et al.DNA and Cell Biology|November 9, 2005
Expression of endothelins and their receptors promotes an invasive phenotype of breast tumor cells but is insufficient to induce invasion in benign cellsThorsten Hagemann, Claudia Binder, Lutz Binder, et al.Cancer Research|November 17, 2005
The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cellsHagen Kulbe, Thorsten Hagemann, Piotr W Szlosarek, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2013
Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancerClaudine Neyen, Annette Plüddemann, Subhankar Mukhopadhyay, et al.Carcinogenesis|March 27, 2004
Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteasesThorsten Hagemann, Stephen C Robinson, Matthias Schulz, et al.Cancer Research|April 3, 2004
A role for endothelin-2 and its receptors in breast tumor cell invasionMatthew J Grimshaw, Thorsten Hagemann, Ayse Ayhan, et al.Molecular Cancer Therapeutics|July 11, 2007
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesisThorsten Hagemann, Stephen C Robinson, Richard G Thompson, et al.Molecular Cancer Therapeutics|August 13, 2009
Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasisClaudia Binder, Thorsten Hagemann, Swetlana Sperling, et al.Pageof 12